Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 4 chloro 3 hydroxybutanoate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103255183B details enzymatic synthesis of S-CHBE. High purity and yield offer supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN112143688A reveals a novel recombinant E. coli strain for high-purity (S)-CHBE production, offering significant cost reduction in API manufacturing.